Skip to main content
. 2022 Sep 14;10(9):e004219. doi: 10.1136/jitc-2021-004219

Figure 3.

Figure 3

CD155+ macrophages (THP-1-derived) enhanced the migration and invasion of human CRC cells. The migration (A), invasion (B), cell cycle status (C), apoptosis (D), and proliferation rate (E) of CRC cells (HTC116) during co-cultured with hCD155+ or hCD155– macrophages. Scale bar: 100 µm. (F and G) MMPs expression in CRC cells during co-cultured with hCD155+ or hCD155– macrophages. (H) Expression pattern of MMPs and pSTAT3/STAT3 in CRC cells during co-cultured with hCD155+ or hCD155– macrophages with or without inhibition of STAT3 or TGF-β signaling. Data were presented as mean±SD, n=3. A significant difference between the groups, **p<0.01, ***p<0.001, and ****p<0.0001. ns, no significant difference. Tofacitinib (2.5 µM): JAK/STAT3 signaling inhibitor, galunisertib (10 µM): TGF-β signaling inhibitor. CRC, colorectal cancer; MMP, matrix metalloproteinases; TGF, transforming growth factor.